Panel: Method For Detecting Gene Mutations Wrongly Declared Obvious By Board
WASHINGTON, D.C. — In a win for an oncology company, the Federal Circuit U.S. Court of Appeals on May 5 vacated and remanded findings by the Patent Trial and Appeal Board...To view the full article, register now.
Already a subscriber? Click here to view full article